190 related articles for article (PubMed ID: 15446804)
1. Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas.
Marcu L; van Doorn T; Olver I
Phys Med Biol; 2004 Aug; 49(16):3767-79. PubMed ID: 15446804
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture.
Tarnawski R; Widel M; Skladowski K
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1074-81. PubMed ID: 12605987
[TBL] [Abstract][Full Text] [Related]
3. The HYP-RT hypoxic tumour radiotherapy algorithm and accelerated repopulation dose per fraction study.
Harriss-Phillips WM; Bezak E; Yeoh E
Comput Math Methods Med; 2012; 2012():363564. PubMed ID: 22778783
[TBL] [Abstract][Full Text] [Related]
4. The mechanisms of acceleration of repopulation in squamous epithelia during daily irradiation.
Trott KR
Acta Oncol; 1999; 38(2):153-7. PubMed ID: 10227435
[TBL] [Abstract][Full Text] [Related]
5. Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions.
Dörr W
Int J Radiat Biol; 1997 Dec; 72(6):635-43. PubMed ID: 9416785
[TBL] [Abstract][Full Text] [Related]
6. Influence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancer.
Marcu LG; Bezak E
Cell Prolif; 2012 Oct; 45(5):404-12. PubMed ID: 22775509
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.
Harriss-Phillips WM; Bezak E; Yeoh EK
Br J Radiol; 2011 Oct; 84(1006):903-18. PubMed ID: 21933980
[TBL] [Abstract][Full Text] [Related]
8. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
[TBL] [Abstract][Full Text] [Related]
9. Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.
Fenwick JD; Pardo-Montero J; Nahum AE; Malik ZI
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1021-30. PubMed ID: 21377280
[TBL] [Abstract][Full Text] [Related]
10. Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy.
Marcu LG
Cell Prolif; 2014 Aug; 47(4):318-25. PubMed ID: 24824866
[TBL] [Abstract][Full Text] [Related]
11. Accelerated repopulation in head and neck cancer.
Withers HR; Maciejewski B; Taylor JM; Hliniak A
Front Radiat Ther Oncol; 1988; 22():105-10. PubMed ID: 3350350
[No Abstract] [Full Text] [Related]
12. Modulation of repopulation processes in oral mucosa: experimental results.
Dörr W
Int J Radiat Biol; 2003 Jul; 79(7):531-7. PubMed ID: 14530162
[TBL] [Abstract][Full Text] [Related]
13. Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice.
Hessel F; Krause M; Petersen C; Hörcsöki M; Klinger T; Zips D; Thames HD; Baumann M
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):510-8. PubMed ID: 14751522
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
[TBL] [Abstract][Full Text] [Related]
15. [For which tumor entities are effects of overall treatment time on the results of radiotherapy evident?].
Stuschke M; Marnitz S; Wurm R; Budach V
Strahlenther Onkol; 2000 Oct; 176(10):462-5. PubMed ID: 11068591
[TBL] [Abstract][Full Text] [Related]
16. Repopulation in radiation oncology: perspectives of clinical research.
Bentzen SM
Int J Radiat Biol; 2003 Jul; 79(7):581-5. PubMed ID: 14530167
[TBL] [Abstract][Full Text] [Related]
17. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
18. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation.
Taylor JM; Withers HR; Mendenhall WM
Radiother Oncol; 1990 Feb; 17(2):95-102. PubMed ID: 2320748
[TBL] [Abstract][Full Text] [Related]
19. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
20. Accelerated fractionation using the concomitant boost: a contribution of radiobiology to radiotherapy.
Peters LJ
BJR Suppl; 1992; 24():200-3. PubMed ID: 1290701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
